Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NPC1L1 | Q9UHC9 | 1/20 | 0.79 |
| ▸ | PTPN1 | P18031 | 1/20 | 0.73 |
| ▸ | CYP17A1 | P05093 | 4/20 | 0.71 |
| ▸ | MAPT | P10636 | 2/20 | 0.71 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.71 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.71 |
| ▸ | USP2 | O75604 | 2/20 | 0.65 |
| ▸ | LMNA | P02545 | 5/20 | 0.64 |
| ▸ | HSD17B10 | Q99714 | 3/20 | 0.64 |
| ▸ | CYP3A4 | P08684 | 3/20 | 0.64 |
| ▸ | TSHR | P16473 | 3/20 | 0.64 |
| ▸ | NR3C1 | P04150 | 2/20 | 0.64 |
| ▸ | SHBG | P04278 | 2/20 | 0.64 |
| ▸ | PGR | P06401 | 2/20 | 0.64 |
| ▸ | SERPINA6 | P08185 | 2/20 | 0.64 |
| ▸ | AR | P10275 | 2/20 | 0.64 |
| ▸ | CYP19A1 | P11511 | 2/20 | 0.64 |
| ▸ | SNCA | P37840 | 2/20 | 0.64 |
| ▸ | CACNA1C | Q13936 | 2/20 | 0.64 |
| ▸ | CYP51A1 | Q16850 | 2/20 | 0.64 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| 4-Cholesten 3-One SCHEMBL55896 | 0.98 | NPC1L1 (0.79) | NPC1L1PTPN1CYP17A1MAPTKDM4E | |
| 4-Cholesten 3-One SCHEMBL19506686 | 0.98 | NPC1L1 (0.79) | NPC1L1PTPN1CYP17A1MAPTKDM4E | |
| 4-Cholesten 3-One SCHEMBL2600424 | 0.98 | NPC1L1 (0.79) | NPC1L1PTPN1CYP17A1MAPTKDM4E | |
| 4-Cholesten 3-One SCHEMBL23452819 | 0.98 | NPC1L1 (0.79) | NPC1L1PTPN1CYP17A1MAPTKDM4E | |
| 4-Cholesten 3-One SCHEMBL10308280 | 0.98 | NPC1L1 (0.79) | NPC1L1PTPN1CYP17A1MAPTKDM4E | |
| 4-Cholesten 3-One SCHEMBL24151936 | 0.98 | NPC1L1 (0.79) | NPC1L1PTPN1CYP17A1MAPTKDM4E | |
| 4-Cholesten 3-One SCHEMBL20094570 | 0.98 | NPC1L1 (0.79) | NPC1L1PTPN1CYP17A1MAPTKDM4E | |
| 4-Cholesten 3-One SCHEMBL25996870 | 0.98 | NPC1L1 (0.79) | NPC1L1PTPN1CYP17A1MAPTKDM4E | |
| 4-Cholesten 3-One SCHEMBL21176042 | 0.98 | NPC1L1 (0.79) | NPC1L1PTPN1CYP17A1MAPTKDM4E | |
| 4-Cholesten 3-One SCHEMBL1688732 | 0.98 | NPC1L1 (0.79) | NPC1L1PTPN1CYP17A1MAPTKDM4E |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2130916-B1 | E. COLI CAPABLE OF EXPRESSING CYTOCHROME P-450, AND BIOCONVERSION METHOD USING THE SAME | MICROBIOPHARM JAPAN CO LTD (JP) | 2015-09-02 | — | — | EP | disclosed |
| US-8735135-B2 | Transformed strains originated from multidrug efflux protein defective strains and a method for microbial conversion using them | MICROBIOPHARM JAPAN CO., LTD (JP) | 2014-05-27 | — | — | US | disclosed |
| EP-2130907-B1 | TRANSFORMED STRAIN DERIVED FROM STRAIN DEFICIENT IN MULTIDRUG EFFLUX PROTEIN, AND BIOCONVERSION METHOD USING THE SAME | MICROBIOPHARM JAPAN CO LTD (JP) | 2013-06-12 | — | — | EP | disclosed |
| US-8460915-B2 | Escherichia coli expressing the cytochrome P-450 gene and a method for microbial conversion using them | MICROBIOPHARM JAPAN CO., LTD. (JP) | 2013-06-11 | — | — | US | disclosed |
| US-20120040441-A1 | TRANSFORMED STRAINS ORIGINATED FROM MULTIDRUG EFFLUX PROTEIN DEFECTIVE STRAINS AND A METHOD FOR MICROBIAL CONVERSION USING THEM | MERCIAN CORPORATION (JP) | 2012-02-16 | — | — | US | disclosed |
| US-20100285565-A1 | ESCHERICHIA COLI EXPRESSING THE CYTOCHROME P-450 GENE AND A METHOD FOR MICROBIAL CONVERSION USING THEM | SANLI HOLDINGS CO., LTD. (JP) | 2010-11-11 | — | — | US | disclosed |
| EP-2130916-A1 | E. COLI CAPABLE OF EXPRESSING CYTOCHROME P-450, AND BIOCONVERSION METHOD USING THE SAME | MERCIAN CORPORATION (JP) | 2009-12-09 | — | — | EP | disclosed |
| EP-2130907-A1 | TRANSFORMED STRAIN DERIVED FROM STRAIN DEFICIENT IN MULTIDRUG EFFLUX PROTEIN, AND BIOCONVERSION METHOD USING THE SAME | MERCIAN CORPORATION (JP) | 2009-12-09 | — | — | EP | disclosed |